Suppr超能文献

儿茶酚胺并非耳蜗传入神经递质的证据。

Evidence that catecholamines are not the afferent transmitter in the cochlea.

作者信息

Klinke R, Evans E F

出版信息

Exp Brain Res. 1977 Jun 27;28(3-4):315-24. doi: 10.1007/BF00235713.

Abstract

Beta-receptor blocking agents (practolol, propranolol) and alpha-receptor blocking agents (phenoxybenzamine, phentolamine), when applied intracochlearly do not eliminate the afferetn discharges or compound action potential of the cochlear nerve. Under the assumption that the drugs used reach the synaptic site, it is therefore concluded that these drugs do not interfere with afferent synaptic transmission. Phentolamine,, however, has a toxic effect upon the cochlea independent from the synaptic process. Local application of catecholamines does not increase spontaneous activity of single fibres of the cochlear nerve. These findings show that catecholamines are not likely to be the afferent transmitter.

摘要

β受体阻断剂(心得宁、普萘洛尔)和α受体阻断剂(酚苄明、酚妥拉明)经耳蜗内给药时,并不会消除耳蜗神经的传入放电或复合动作电位。因此,在所用药物能到达突触部位的假设下,可以得出结论:这些药物不会干扰传入性突触传递。然而,酚妥拉明对耳蜗具有独立于突触过程的毒性作用。局部应用儿茶酚胺不会增加耳蜗神经单纤维的自发放电活动。这些发现表明,儿茶酚胺不太可能是传入性递质。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验